The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
-
MD First Research - Chandler, Chandler, Arizona, United States, 85286
Tucson Orthopaedic Institute - North Wyatt Drive, Tucson, Arizona, United States, 85712
Ark Clinical Research - Fountain Valley, Fountain Valley, California, United States, 92708
St Joseph Heritage Healthcare, Fullerton, California, United States, 92835
Clinical Research Institute, Los Angeles, California, United States, 90048
Artemis Institute for Clinical Research, San Diego, California, United States, 92103
Alpine Clinical Research Center, Boulder, Colorado, United States, 80301
K2 Medical Research - Daytona Beach, Daytona Beach, Florida, United States, 32114
Suncoast Research Group, Miami, Florida, United States, 33135
IMA Clinical Research St. Petersburg, Saint Petersburg, Florida, United States, 33704
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Eli Lilly and Company,
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), STUDY_DIRECTOR, Eli Lilly and Company
2027-09